48.65
-1.32%
Close of 9 Nov 2026, in CHF
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Coltene Holding
Its shares trade on SIX under the ticker CLTN.SW. It has been listed since 23 June 2006. In the fiscal year to 31 December 2025, it reported revenue of CHF 240.0m and net income of CHF 14.9m. At that date it held total assets of CHF 184.8m and shareholders' equity of CHF 100.5m.
Coltene Holding AG is engaged in the development, production, and sale of tools and equipment of dental consumables. The company is headquartered in Altstaetten, St. Gallen. The company went IPO on 2006-06-23. The company develops, manufactures and sells dental consumables and small equipment focusing on mechanical instruments and filling materials. The company has production facilities in Switzerland, the United States, Germany and Hungary. The firm's product range comprises six product groups: Adhesives / Restoratives; Endodontics; Prosthetics; Rotary Instruments; Treatment Auxiliaries; and Hygiene. Coltene Holding AG has a number of wholly owned subsidiaries active in production and sales of dental specialties based in Switzerland, Germany, Hungary, Canada, the United Kingdom, France, China, India, the United States and Brazil.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 23 Jun 2006
- Employees
- 1,395
- Website
- coltene.com ↗
Leadership
Pay as last reported
- Mr. Nick HuberNon-Executive Chairman of the Board of DirectorsCHF 115,308
- Mr. Dominik ArnoldChief Executive Officer, Member of the Management BoardCHF 889,119
- Mr. Markus AbderhaldenChief Financial Officer, Member of the Management Board
- Mr. Gregor PicardChief Operating Officer, Member of the Management Board
- Dr. Martin SchlueterChief Technology Officer, Member of the Management Board
- Mr. Mattias FlodinChief Marketing Officer, Member of the Management Board
- Mr. Paul FreyChief Sales Officer, North America, Member of the Management Board
- Mr. Di HuChief Sales Officer, Europe and Rest of the World, Member of the Management Board
- Mr. Matthias AltendorfNon-Executive Member of the Board of DirectorsCHF 80,572
- Mr. Daniel BuhlerNon-Executive Member of the Board of DirectorsCHF 80,572
- Mr. Juergen RauchNon-Executive Member of the Board of DirectorsCHF 80,436
- Mr. Edgar SchonbachlerNon-Executive Member of the Board of DirectorsCHF 55,587
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 70
- Environment
- 55
- Social
- 99
- Governance
- 57
- Direct emissions (scope 1)
- 1,749 t
- Energy emissions (scope 2)
- 1,233 t
- Women in the workforce
- 46%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Coltene Holding AG has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation and is recognized as a leading provider of dental consumables and solutions. This brand recognition helps Coltene attract and retain customers. Secondly, Coltene has a diverse range of high-quality products in its portfolio. This enables the company to meet the varied needs of dental professionals and offer innovative solutions for different dental procedures. Additionally, Coltene has a global presence with a strong distribution network. This ensures that its products are readily available to customers worldwide and allows the company to tap into various international markets. Furthermore, Coltene has a dedicated and skilled workforce. The company invests in employee training and development, resulting in a team that is knowledgeable and capable of providing exceptional customer service. Lastly, Coltene has a strong financial position and consistent revenue growth. This provides the company with the resources needed for research and development, as well as expansion and investment opportunities.
Weaknesses
- Despite its strengths, Coltene Holding AG also faces some weaknesses that may hinder its growth and performance. One major weakness is its dependency on the dental industry. Any changes or fluctuations in the dental market can directly impact the company's sales and profitability. Another weakness is the potential for increased competition in the market. The dental industry is highly competitive, with several established players and new entrants. Coltene must continuously innovate and differentiate its products to maintain its market share and stay ahead of competitors. Additionally, Coltene's global presence exposes it to currency exchange rate risks. Fluctuations in exchange rates can affect the company's profitability when converting foreign currency into its reporting currency. Lastly, Coltene's product portfolio may lack diversification in terms of non-dental healthcare solutions. This limited diversification exposes the company to potential risks from changes in the dental industry or market preferences.
Opportunities
- Despite the challenges, Coltene Holding AG can leverage various opportunities in the market. Firstly, the increasing demand for dental treatments and the overall growth of the dental industry present a significant opportunity for Coltene to expand its customer base and increase sales. Secondly, there is a growing focus on aesthetics and cosmetic dentistry, which opens up new market segments for Coltene. By developing and marketing innovative and high-quality products specifically tailored to this segment, the company can capture a larger share of this lucrative market. Furthermore, Coltene can explore strategic partnerships and collaborations with other healthcare companies. By combining resources and expertise, Coltene can develop integrated solutions that offer comprehensive dental care and attract more customers. Lastly, Coltene has the potential to expand its product portfolio beyond dental consumables and solutions. By diversifying into related areas of healthcare, such as orthodontics or oral care, the company can tap into new revenue streams and reduce its dependency on the dental industry.
Threats
- Coltene Holding AG faces several threats that may impact its business operations and performance. One major threat is the strict regulatory environment in the dental industry. Compliance with regulations and obtaining necessary approvals for products can be time-consuming and costly for the company. Additionally, the entry of low-cost competitors, especially from emerging markets, poses a threat to Coltene's market share. These low-cost alternatives may attract price-sensitive customers and erode Coltene's profitability. Furthermore, advancements in technology and materials may disrupt the dental industry and render some of Coltene's products obsolete. Staying updated with technological advancements and investing in research and development is crucial to mitigate this threat. Lastly, the ongoing COVID-19 pandemic has negatively impacted the dental industry, leading to reduced dental visits and lower demand for dental consumables. This external factor has put pressure on Coltene's revenue and profitability, highlighting the vulnerability of the company to external shocks and crises.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.